Replying to @⁨Mustachius_Grumpius@thelemmy.club⁩

related research:

scmp.com/…/chinese-drug-loberamisal-extends-strok…

Chinese drug loberamisal extends stroke treatment window from 6 hours to 2 days

“The large-scale multicentre phase 3 trial found that 70 per cent of patients who received loberamisal intravenously within two days of a stroke regained complete functional independence – an increase of 13 percentage points over standard care alone.”